$VRTX News Article - FDA Approves SYMDEKO (tezaca
Post# of 76
(Total Views: 318)
Posted On: 06/21/2019 4:25:43 PM
$VRTX News Article - FDA Approves SYMDEKO (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of CF in Children Ages 6-11 Years with Certain Mutations in the CFTR Gene https://marketwirenews.com/news-releases/fda-...96924.html
(0)
(0)Vertex Pharmaceuticals Inc. (VRTX) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼